Rafael Holdings, Inc. Class B RFL 深 滬
等待開盤 09-11 09:30:00 美东时间
1.33
-0.110
-7.64%
華盛通- 最 高1.51
- 今 開1.50
- 成交量 12.12万股
- 最 低 1.32
- 昨 收 1.44
- 總市值 4667.02万
- 52周最高 3.19
- 市盈率 靜 --
- 換手率 0.35%
- 52周最低 1.28
- 委 比 -42.86%
- 總股本 3509.04万
- 歷史最高 65.5004
- 量 比 0.74
- 振 幅 13.19%
- 歷史最低 1.2718
- 每 手 1
- 風險率 0.23%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多前中国商飞团队转战eVTOL、合作滴滴出行，拿下数亿元A轮融资｜硬氪首发
作者|林晴晴 编辑|袁斯来 硬氪获悉，电动垂直起降飞行器（eVTOL）研发制造商「亿维特航空」近日完成数亿元人民...
08-28 14:45
Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM)
Rafael Holdings, Inc. announced that its subsidiary, Cyclo Therapeutics, has had two abstracts selected for presentation at the 15th International Congress of Inborn Errors of Metabolism (ICIEM) in Kyoto, Japan. The presentations will highlight Trappsol® Cyclo™'s efficacy and safety in treating Niemann-Pick Disease Type C1 (NPC1) based on clinical studies and an expanded access program. The oral presentation, led by Dr. Caroline Hastings, will di...
08-27 12:00
Rafael Holdings Announces Executive Team Changes
The latest update is out from Rafael Holdings ( ($RFL) ). On August 4, 2025, Ra...
08-08 05:47
Rafael Holdings Elects N. Scott Fine as Vice Chairman
Rafael Holdings ( ($RFL) ) has shared an update. On July 14, 2025, Rafael Holdi...
07-18 20:57
Butterfly Gandhimathi Announces Virtual AGM with E-Voting
The latest update is out from Butterfly Gandhimathi Appliances Limited ( ($IN:B...
06-29 03:24
Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data
Rafael Holdings announced that its subsidiary Cyclo Therapeutics' 96-week pivotal phase 3 TransportNPC study evaluating intravenous Trappsol® Cyclo™ for the potential treatment of Niemann-Pick Disease Type C1 (NPC1) will continue following a favorable interim analysis by an independent Data Monitoring Committee (DMC) and FDA acceptance of the statistical analysis plan. TrappsolCyclo has shown a favorable safety profile in phase 1, 2, and ongoing ...
06-18 11:00
Rafael Holdings shares are trading lower. The company reported Q3 financial results.
Rafael Holdings shares are trading lower. The company reported Q3 financial res...
06-12 00:49
Rafael Holdings Q3 EPS $(0.19) Up From $(1.36) YoY, Sales $362.00K Up From $336.00K YoY
Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.19) per share. This is a 86.03 percent increase over losses of $(1.36) per share from the same period last year. The company reported $362.00 thousand in sales
06-11 19:24
Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering
Rafael Holdings, Inc. completed a $25 million rights offering, raising $4.007 million through 3.13 million Class B shares at $1.28 each. Howard Jonas, CEO, and affiliates initially holding 32% of shares did not exercise their rights due to a backstop commitment, purchasing unsubscribed shares for $20.99 million. The offering and backstop placement total $24.9 million net proceeds, supporting regulatory efforts and potential launch of Trappsol Cyc...
06-04 20:01
Rafael Holdings Updates Terms Of Rights Offering, Granting 1 Non-Transferable Subscription Right Per Share Or Equivalent Public Warrant Held As Of May 9, 2025, Allowing Holders To Purchase 0.603 Shares Of Class B Common Stock At $1.28 Per Share, With Public Warrant Holders Receiving 0.3525 Rights Per Warrant And Full Rights Granted Per 3 Warrants Held
Rafael Holdings, Inc. (NYSE:RFL, NYSE:RFL) today provided an update to the subscription rights related to its Public Warrants in connection with its previously announced rights offering.Under the rights offering, Rafael
05-21 04:03
